Research News at Hollings

Hollings smoking cessation expert determines benefits of early action to quit smoking after cancer diagnosis

a word cloud in the shape of an apple with Quit Smoking being the most prominent and other words including life, muscle and more

A study from Graham Warren, M.D., Ph.D., found that quitting smoking within six months after a cancer diagnosis adds an average of two years to a patient’s life. This reaffirms the broad survival benefit of using evidence-based smoking cessation to help patients quit as soon as possible.

“This is a survival benefit that we can achieve now. It isn't something that we need to wait 10 years for trial results,” he said.

Read about the study

two women in business casual attire pose in a garden setting

Cannabis and Cancer

Cancer patients who smoke cigarettes are more likely than nonsmokers to use cannabis, researchers find.

a researcher in a white coat in a lab setting

Harnessing AI

An artificial intelligence initiative underway at Hollings seeks to provide oncologists with insights into customized treatment options for individual patients.
a man and woman in white lab coats in a lab setting talking and working

Modeling Ovarian Cancer

Models help scientists understand how cancer develops - but researchers haven't had one for most ovarian cancers.

Wyatt Wofford (left) and Dr. Besim Ogretmen (right)

Immunotherapy in Breast Cancer

MUSC Hollings researchers find that targeting an immunosuppressive protein on two fronts can reduce metastasis and restore sensitivity to immunotherapy.
Kaycen Martin in a hospital bed wearing a superhero mask

Childhood Cancer Report

An MUSC children’s cancer specialist and other experts from across state find 11% improvement in childhood cancer survival over 25-year period.
a man and woman in business casual pose in a hallway at Hollings Cancer Center

Depression and Cancer

Two Hollings researchers are working together to develop a new way to get depression treatment to people with likely incurable cancer.

tobacco and vaping researcher Matthew Carpenter poses in a suit in lush green outdoor garden setting

DUET

A new study aims to get a better understanding of what dual use of vapes and cigarettes looks like in real world usage.

image of Jezabel Rodriguez Blanco in white lab coat and gloves sitting at the bench in her lab at Hollings Cancer Center

Medulloblastoma Research

The Group 3 subtype of medulloblastoma has the worst prognosis of all the subtypes, but new research is pointing to a potential therapy.

group shot of three cancer scientists in a lab at Hollings Cancer Center

Triple Negative Breast Cancer

A new compound developed by researchers at MUSC Hollings Cancer Center shows promise in overcoming chemotherapy resistance in triple-negative breast cancer.